Skip to content
DrBrainRxDrBrainRx
0
Personalized care from experts
Personalized care from experts
Fast & discreet shipping
Fast & discreet shipping
100% online visits
100% online visits
Personalized care from experts
Personalized care from experts
Fast & discreet shipping
Fast & discreet shipping
100% online visits
100% online visits

Reinvent your‎ ‎ Brain Body Passion Beauty

Personalized care from experts

Personalized care from experts

Fast & discreet shipping

Fast & discreet shipping

100% online visits

100% online visits

What Happens When You Stop GLP-1s?

What Happens When You Stop GLP-1s?

Why Some People Regain Weight

GLP-1s help you retrain appetite and metabolism, not replace them. When you discontinue, gut hormones, hunger, and reward pathways gradually return to baseline.
If lifestyle habits and muscle mass aren’t in place, it’s easy for caloric intake to rise before metabolism catches up, leading to regain.

In the STEP-1 extension trial, participants regained about two-thirds of lost weight within a year of stopping—but those who maintained protein intake and exercise kept far more off.


 

What You Can Expect

  • Appetite returns: Usually within 4–6 weeks.

  • Blood sugar may fluctuate: Especially if insulin-resistant pre-treatment.

  • Energy stabilizes: Many feel more hunger cues but improved mood and libido.


 

How to Transition Off Safely

  1. Taper, don’t stop cold turkey. Gradual reduction minimizes rebound hunger.

  2. Add peptide support. CJC-1295 ipamorelin telehealth or BPC-157 maintain metabolic tone.

  3. Focus on muscle. Resistance training + creatine keep metabolism high.

  4. Track protein and steps. Aim for 100–120 g protein/day and 7–10k steps.


 

The DrBrainRx “Off-Ramp” Protocol

Our patients use a GLP-1 taper + peptide bridge to sustain weight and mood benefits while hormones normalize.

If you’re considering pausing your injections, schedule a personalized transition plan at drbrainrx.com/

References

  1. Wilding JPH et al. NEJM. 2022;387:2114-2125.

  2. Garvey WT et al. Diabetes Care. 2023;46:1129-1138.

  3. ADA Clinical Update 2024.

 

Cart 0

Your cart is currently empty.

Start Shopping